Rheo‐Erythrocrine Dysfunction as a Biomarker for Remote Ischemic Conditioning Treatment in Acute Ischemic Stroke: A Pilot Randomized Controlled Trial
Journal of the American Heart Association · 2023
DOI: 10.1161/jaha.123.031466 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of the American Heart Association, 2023. Verfasst von Maria Kjølhede und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology Aarhus University Hospital Aarhus Denmark. Hauptthemen laut MEDLINE: Biomarkers, Ischemic Stroke. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 5 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Schlaganfall
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology Aarhus University Hospital Aarhus Denmark.
- Department of Clinical Medicine Aarhus University Aarhus Denmark.
- Danish Center for Clinical Health Services Research, Department of Clinical Medicine Aalborg University Aalborg Denmark.
- Department of Clinical Biochemistry Aarhus University Hospital Aarhus Denmark.
- Department of Hematology Aarhus University Hospital Aarhus Denmark.
- Department of Biomedicine Aarhus University Aarhus Denmark.
ORCID-Profile: Maria Kjølhede, Grethe Andersen, Jan Brink Valentin, Marlene Christina Nielsen, Morten Nørgaard Andersen, Mohammad Badruzzaman Khan, Jesper Nørgaard Bech, David C Hess, Rolf Ankerlund Blauenfeldt
Zitieren
APA
Kjølhede, M., Andersen, G., Valentin, J. B., Nielsen, M. C., Andersen, M. N., Khan, M. B., Bech, J. N., Hess, D. C., & Blauenfeldt, R. A. (2023). Rheo‐Erythrocrine Dysfunction as a Biomarker for Remote Ischemic Conditioning Treatment in Acute Ischemic Stroke: A Pilot Randomized Controlled Trial. Journal of the American Heart Association. https://doi.org/10.1161/jaha.123.031466
Vancouver
Kjølhede M, Andersen G, Valentin JB, Nielsen MC, Andersen MN, Khan MB, et al. Rheo‐Erythrocrine Dysfunction as a Biomarker for Remote Ischemic Conditioning Treatment in Acute Ischemic Stroke: A Pilot Randomized Controlled Trial. Journal of the American Heart Association. 2023. doi:10.1161/jaha.123.031466
BibTeX
@article{Kjlhede2023,
author = {Kjølhede, Maria and Andersen, Grethe and Valentin, Jan Brink and Nielsen, Marlene Christina and Andersen, Morten Nørgaard and Khan, Mohammad Badruzzaman and Bech, Jesper Nørgaard and Hess, David C and Blauenfeldt, Rolf Ankerlund},
title = {Rheo‐Erythrocrine Dysfunction as a Biomarker for Remote Ischemic Conditioning Treatment in Acute Ischemic Stroke: A Pilot Randomized Controlled Trial},
journal = {Journal of the American Heart Association},
year = {2023},
doi = {10.1161/jaha.123.031466}
}
EUVIMED